2023 Q3 Form 10-Q Financial Statement
#000092416823000084 Filed on August 10, 2023
Income Statement
| Concept | 2023 Q3 | 2023 Q2 |
|---|---|---|
| Revenue | $1.339M | $1.055M |
| YoY Change | -24.09% | -28.72% |
| Cost Of Revenue | $1.387M | $876.0K |
| YoY Change | -28.02% | -36.11% |
| Gross Profit | -$48.00K | $179.0K |
| YoY Change | -70.55% | 64.22% |
| Gross Profit Margin | -3.58% | 16.97% |
| Selling, General & Admin | $713.0K | $1.132M |
| YoY Change | -60.43% | -42.36% |
| % of Gross Profit | 632.4% | |
| Research & Development | $142.0K | $147.0K |
| YoY Change | -61.2% | -58.36% |
| % of Gross Profit | 82.12% | |
| Depreciation & Amortization | $8.000K | $8.000K |
| YoY Change | -80.95% | -81.4% |
| % of Gross Profit | 4.47% | |
| Operating Expenses | $855.0K | $1.279M |
| YoY Change | -61.9% | -44.8% |
| Operating Profit | -$903.0K | -$1.100M |
| YoY Change | -62.48% | -50.18% |
| Interest Expense | $34.00K | $69.00K |
| YoY Change | -85.53% | -73.46% |
| % of Operating Profit | ||
| Other Income/Expense, Net | -$10.00K | -$14.00K |
| YoY Change | -89.58% | -22.22% |
| Pretax Income | -$940.0K | -$1.167M |
| YoY Change | -64.69% | -53.06% |
| Income Tax | ||
| % Of Pretax Income | ||
| Net Earnings | -$944.0K | -$1.167M |
| YoY Change | -64.54% | -53.06% |
| Net Earnings / Revenue | -70.5% | -110.62% |
| Basic Earnings Per Share | ||
| Diluted Earnings Per Share | -$0.27 | -$0.42 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 3.495M shares | 19.24M shares |
| Diluted Shares Outstanding | 3.514M shares | 2.766M shares |
Balance Sheet
| Concept | 2023 Q3 | 2023 Q2 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $2.420M | $1.946M |
| YoY Change | 271.74% | 35.23% |
| Cash & Equivalents | $1.691M | $1.316M |
| Short-Term Investments | $730.0K | $630.0K |
| Other Short-Term Assets | $190.0K | $217.0K |
| YoY Change | -75.89% | -74.38% |
| Inventory | $4.901M | $5.304M |
| Prepaid Expenses | ||
| Receivables | $844.0K | $841.0K |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $8.357M | $8.308M |
| YoY Change | -2.85% | -21.69% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $1.050M | $1.094M |
| YoY Change | -37.54% | -42.45% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | ||
| YoY Change | ||
| Total Long-Term Assets | $1.046M | $1.094M |
| YoY Change | -37.78% | -42.45% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $8.357M | $8.308M |
| Total Long-Term Assets | $1.046M | $1.094M |
| Total Assets | $9.403M | $9.402M |
| YoY Change | -8.56% | -24.84% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $2.600M | $2.908M |
| YoY Change | 37.86% | 122.15% |
| Accrued Expenses | $790.0K | $861.0K |
| YoY Change | -22.47% | -33.15% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $284.0K |
| YoY Change | -100.0% | -85.66% |
| Long-Term Debt Due | $1.270M | $1.335M |
| YoY Change | -35.6% | -27.45% |
| Total Short-Term Liabilities | $4.654M | $5.388M |
| YoY Change | -32.16% | -16.05% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $0.00 | $0.00 |
| YoY Change | -100.0% | -100.0% |
| Other Long-Term Liabilities | $860.0K | $915.0K |
| YoY Change | -20.52% | -19.24% |
| Total Long-Term Liabilities | $860.0K | $915.0K |
| YoY Change | -54.67% | -52.37% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $4.654M | $5.388M |
| Total Long-Term Liabilities | $860.0K | $915.0K |
| Total Liabilities | $5.511M | $6.303M |
| YoY Change | -37.07% | -24.42% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$152.5M | -$151.5M |
| YoY Change | 3.92% | 5.19% |
| Common Stock | $156.4M | $154.6M |
| YoY Change | 5.48% | 4.32% |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $3.892M | $3.099M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $9.403M | $9.402M |
| YoY Change | -8.56% | -24.84% |
Cashflow Statement
| Concept | 2023 Q3 | 2023 Q2 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$944.0K | -$1.167M |
| YoY Change | -64.54% | -53.06% |
| Depreciation, Depletion And Amortization | $8.000K | $8.000K |
| YoY Change | -80.95% | -81.4% |
| Cash From Operating Activities | -$1.035M | -$152.0K |
| YoY Change | 16.16% | -94.25% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $27.00K | $0.00 |
| YoY Change | 200.0% | -100.0% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | ||
| YoY Change | ||
| Cash From Investing Activities | -$27.00K | $0.00 |
| YoY Change | 200.0% | -100.0% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | $1.437M | $1.167M |
| YoY Change | 47800.0% | -65.24% |
| NET CHANGE | ||
| Cash From Operating Activities | -$1.035M | -$152.0K |
| Cash From Investing Activities | -$27.00K | $0.00 |
| Cash From Financing Activities | $1.437M | $1.167M |
| Net Change In Cash | $375.0K | $1.015M |
| YoY Change | -141.81% | 42.36% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$1.035M | -$152.0K |
| Capital Expenditures | $27.00K | $0.00 |
| Free Cash Flow | -$1.062M | -$152.0K |
| YoY Change | 18.0% | -94.25% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4864000 | usd | |
| CY2022Q2 | us-gaap |
Interest Expense
InterestExpense
|
260000 | usd |
| us-gaap |
Interest Expense
InterestExpense
|
192000 | usd | |
| CY2023Q2 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
14000 | usd |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-2500000 | usd | |
| CY2023Q2 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
-0.42 | |
| CY2023Q2 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
284000 | usd |
| CY2022Q4 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
1447000 | usd |
| CY2023Q2 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.142857 | |
| CY2023Q2 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.142857 | |
| CY2022 | us-gaap |
Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
|
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate201613Member | |
| CY2023Q2 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.142857 | |
| CY2023Q2 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.142857 | |
| CY2023Q2 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.142857 | |
| CY2023Q2 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.142857 | |
| CY2023Q2 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.142857 | |
| CY2023Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
2908000 | usd |
| CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
2204000 | usd |
| CY2023Q2 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
116000 | usd |
| CY2022Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
145000 | usd |
| CY2023Q2 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
89000 | usd |
| CY2022Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
0 | usd |
| CY2023Q2 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
268000 | usd |
| CY2022Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
261000 | usd |
| CY2023Q2 | us-gaap |
Accrued Sales Commission Current
AccruedSalesCommissionCurrent
|
32000 | usd |
| CY2022Q4 | us-gaap |
Accrued Sales Commission Current
AccruedSalesCommissionCurrent
|
76000 | usd |
| CY2023Q2 | us-gaap |
Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
|
146000 | usd |
| CY2022Q4 | us-gaap |
Standard Product Warranty Accrual Current
StandardProductWarrantyAccrualCurrent
|
183000 | usd |
| CY2023Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
210000 | usd |
| CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
198000 | usd |
| CY2023Q2 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
1335000 | usd |
| CY2022Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
2618000 | usd |
| us-gaap |
Operating Expenses
OperatingExpenses
|
4947000 | usd | |
| CY2023Q2 | us-gaap |
Interest Expense
InterestExpense
|
69000 | usd |
| us-gaap |
Interest Expense
InterestExpense
|
444000 | usd | |
| CY2022Q2 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
18000 | usd |
| us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
21000 | usd | |
| CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1167000 | usd |
| CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2486000 | usd |
| CY2023Q2 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-0.42 | |
| CY2022Q2 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
-2.43 | |
| us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-0.98 | ||
| CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
2766000 | shares |
| CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
2766000 | shares |
| CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1024000 | shares |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
2539000 | shares | |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
2539000 | shares | |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
973000 | shares | |
| CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-477000 | usd |
| CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
|
1716000 | usd |
| CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
26000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1333000 | usd |
| CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2955000 | usd |
| CY2023Q2 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
1304000 | usd |
| CY2023Q2 | us-gaap |
Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
|
0 | usd |
| CY2023Q2 | efoi |
Stock Issued During Period Value Reverse Stock Splits
StockIssuedDuringPeriodValueReverseStockSplits
|
-16000 | usd |
| CY2023Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
23000 | usd |
| CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1167000 | usd |
| CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
6209000 | usd |
| CY2022Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
44000 | usd |
| CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3432000 | usd |
| CY2022Q2 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
5000 | usd |
| CY2022Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
3500000 | usd |
| CY2022Q2 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
334000 | usd |
| CY2023Q2 | us-gaap |
Other Income
OtherIncome
|
0 | usd |
| CY2022Q2 | us-gaap |
Other Income
OtherIncome
|
0 | usd |
| us-gaap |
Other Income
OtherIncome
|
0 | usd | |
| us-gaap |
Other Income
OtherIncome
|
30000 | usd | |
| CY2023Q2 | us-gaap |
Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
|
0 | usd |
| CY2022Q2 | us-gaap |
Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
|
-47000 | usd |
| us-gaap |
Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
|
23000 | usd | |
| us-gaap |
Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
|
-59000 | usd | |
| CY2023Q2 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
884000 | usd |
| CY2022Q2 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-777000 | usd |
| us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
857000 | usd | |
| us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-716000 | usd | |
| CY2023Q2 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-152000 | usd |
| CY2022Q2 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-149000 | usd |
| us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-86000 | usd | |
| us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-360000 | usd | |
| CY2023Q2 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
0 | usd |
| CY2022Q2 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
0 | usd |
| us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
0 | usd | |
| us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-268000 | usd | |
| CY2023Q2 | us-gaap |
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
|
1015000 | usd |
| CY2022Q2 | us-gaap |
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
|
-156000 | usd |
| us-gaap |
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
|
1165000 | usd | |
| us-gaap |
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
|
-38000 | usd | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1335000 | usd | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-5345000 | usd | |
| CY2023Q2 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
0 | usd |
| CY2022Q2 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2000 | usd |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
0 | usd | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
37000 | usd | |
| CY2023Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | usd |
| CY2022Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-2000 | usd |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | usd | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-37000 | usd | |
| CY2023Q2 | efoi |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
1304000 | usd |
| CY2022Q2 | efoi |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
3500000 | usd |
| efoi |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
4329000 | usd | |
| efoi |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
3500000 | usd | |
| CY2023Q2 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
0 | usd |
| CY2022Q2 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
334000 | usd |
| us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
0 | usd | |
| us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
334000 | usd | |
| CY2023Q2 | efoi |
Payments For Offering Costs Associated With Reverse Stock Split
PaymentsForOfferingCostsAssociatedWithReverseStockSplit
|
16000 | usd |
| CY2022Q2 | efoi |
Payments For Offering Costs Associated With Reverse Stock Split
PaymentsForOfferingCostsAssociatedWithReverseStockSplit
|
0 | usd |
| efoi |
Payments For Offering Costs Associated With Reverse Stock Split
PaymentsForOfferingCostsAssociatedWithReverseStockSplit
|
16000 | usd | |
| efoi |
Payments For Offering Costs Associated With Reverse Stock Split
PaymentsForOfferingCostsAssociatedWithReverseStockSplit
|
0 | usd | |
| CY2023Q2 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
0 | usd |
| CY2022Q2 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
0 | usd |
| us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
0 | usd | |
| us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
1000 | usd | |
| CY2023Q2 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
0 | usd |
| CY2022Q2 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
5000 | usd |
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
0 | usd | |
| us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
5000 | usd | |
| CY2023Q2 | us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
0 | usd |
| CY2022Q2 | us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
234000 | usd |
| us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
0 | usd | |
| us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
234000 | usd | |
| CY2023Q2 | us-gaap |
Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
|
-121000 | usd |
| CY2022Q2 | us-gaap |
Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
|
-1170000 | usd |
| us-gaap |
Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
|
-1214000 | usd | |
| us-gaap |
Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
|
-273000 | usd | |
| CY2023Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1167000 | usd |
| CY2022Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
3357000 | usd |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
2599000 | usd | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
3638000 | usd | |
| CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
1015000 | usd |
| CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
713000 | usd |
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
1264000 | usd | |
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-1744000 | usd | |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
301000 | usd |
| CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
225000 | usd |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
52000 | usd |
| CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2682000 | usd |
| CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1316000 | usd |
| CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
938000 | usd |
| CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1316000 | usd |
| CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
938000 | usd |
| us-gaap |
Nature Of Operations
NatureOfOperations
|
NATURE OF<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPERATIONS</span><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Energy Focus, Inc. engages primarily in the design, development, manufacturing, marketing and sale of energy-efficient lighting systems and controls. We develop, market and sell high quality light-emitting diode (“LED”) lighting and controls products in the commercial market and military maritime market (“MMM”). Our mission is to enable our customers to run their facilities with greater energy efficiency, productivity, and increased human health and wellness through advanced LED retrofit solutions. Our goal is to be the human wellness lighting and LED technology and market leader for the most demanding applications where performance, quality, value, environmental impact and health are considered paramount. We specialize in LED lighting retrofit by replacing fluorescent, high-intensity discharge lighting and other types of lamps in institutional buildings for primarily indoor lighting applications with our innovative, high-quality commercial and military-grade tubular LED (“TLED”) products, as well as other LED and lighting control products for commercial applications. We are also evaluating adjacent technologies, including Gallium Nitride (“GaN”) based power supplies and additional market opportunities for energy solution products that support sustainability in our existing channels.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the Company’s annual meeting of stockholders held on June 15, 2023, the Company’s stockholders approved a form of the certificate of amendment (the “Certificate of Amendment”) to the Company’s Certificate of Incorporation, as amended (the “Certificate of Incorporation”), and authorized the board of directors of the Company to amend the Certificate of Incorporation to effect a reverse stock split of the outstanding shares of the Company’s common stock, par value $0.0001 per share, at a ratio ranging from any whole number of at least 1-for-2 and up to 1-for-10, with the exact ratio within the foregoing range to be determined by the board of directors in its sole discretion.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 15, 2023, our board of directors determined to set the reverse stock split ratio at 1-for-7 (the “Split Ratio”). The Certificate of Amendment to our Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on June 15, 2023, with an effective date of June 16, 2023 (the “Effective Time”). At the Effective Time, every seven shares of common stock issued and outstanding automatically combined into one validly issued, fully paid and non-assessable share of common stock. No fractional shares were issued as a result of the reverse stock split. The $0.0001 par value per share of common stock and other terms of the common stock were not affected by the reverse stock split. The number of authorized shares of common stock under the Certificate of Incorporation remained unchanged at 50,000,000 shares. Proportional adjustments were made to the conversion and exercise prices of our outstanding warrants and stock options, and to the number of shares issued and issuable under our stock incentive plans in connection with the reverse stock split. The current financial statements, as well as the prior-period financial statements have been retroactively adjusted to reflect the reverse stock split. Preferred shares outstanding were not affected by the reverse stock split and as such, those shares have not been adjusted.</span></div> | ||
| CY2023Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2023Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2023Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-2500000 | usd | |
| CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10300000 | usd |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1300000 | usd | |
| CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-6700000 | usd |
| CY2023Q2 | efoi |
Common Stock Minimum Bid Price
CommonStockMinimumBidPrice
|
1.00 | |
| CY2022Q2 | efoi |
Common Stock Trade Price Per Share
CommonStockTradePricePerShare
|
1.00 | |
| CY2023Q2 | efoi |
Common Stock Minimum Bid Price
CommonStockMinimumBidPrice
|
1.00 | |
| CY2022Q3 | efoi |
Common Stock Closing Bid Price Threshold
CommonStockClosingBidPriceThreshold
|
1.00 | |
| CY2022Q3 | efoi |
Number Of Consecutive Days For Bid Price Below Threshold
NumberOfConsecutiveDaysForBidPriceBelowThreshold
|
30 | creditfacility |
| CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2500000 | usd |
| CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1500000 | usd |
| us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our financial statements and accompanying notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Although these estimates are based on management’s best knowledge of current events and actions that may impact us in the future, actual results may vary from the estimates. Estimates include, but are not limited to, the establishment of reserves for accounts receivable, sales returns, inventory obsolescence and warranty claims; the useful lives of property and equipment; valuation allowance for net deferred taxes; and stock-based compensation. The Company began using estimates for its calculation of allowance for doubtful accounts receivable under Accounting Standards Codification (“ASC”) 326, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“CECL”) commencing in 2023. In addition, estimates and assumptions associated with the determination of the fair value of financial instruments and evaluation of long-lived assets for impairment requires considerable judgment. Actual results could differ from those estimates and such differences could be material.</span></div> | ||
| CY2023Q2 | us-gaap |
Revenues
Revenues
|
1055000 | usd |
| CY2022Q2 | us-gaap |
Revenues
Revenues
|
1480000 | usd |
| us-gaap |
Revenues
Revenues
|
1985000 | usd | |
| us-gaap |
Revenues
Revenues
|
3541000 | usd | |
| efoi |
Contract With Customer Payment Terms
ContractWithCustomerPaymentTerms
|
P30D | ||
| CY2023Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
12000 | usd |
| CY2023Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
3000 | usd |
| CY2023Q2 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
920000 | usd |
| CY2022Q4 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
471000 | usd |
| CY2022Q1 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
1254000 | usd |
| CY2023Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
79000 | usd |
| CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
26000 | usd |
| CY2022Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
14000 | usd |
| CY2023Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
841000 | usd |
| CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
445000 | usd |
| CY2022Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1240000 | usd |
| CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1167000 | usd |
| CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2486000 | usd |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-2500000 | usd | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-5307000 | usd | |
| CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
2766000 | shares |
| CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
2766000 | shares |
| CY2022Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
1024000 | shares |
| CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
1024000 | shares |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
2539000 | shares | |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
2539000 | shares | |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
973000 | shares | |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
973000 | shares | |
| CY2023Q1 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
143000 | usd |
| CY2022Q1 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
265000 | usd |
| CY2022Q4 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
183000 | usd |
| CY2021Q4 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
295000 | usd |
| CY2023Q2 | us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
3000 | usd |
| CY2022Q2 | us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
7000 | usd |
| us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
2000 | usd | |
| us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
6000 | usd | |
| CY2023Q2 | us-gaap |
Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
|
0 | usd |
| CY2022Q2 | us-gaap |
Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
|
43000 | usd |
| us-gaap |
Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
|
-39000 | usd | |
| us-gaap |
Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
|
28000 | usd | |
| CY2023Q2 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
0 | usd |
| CY2022Q2 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
0 | usd |
| us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
0 | usd | |
| us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
14000 | usd | |
| CY2023Q2 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
146000 | usd |
| CY2022Q2 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
315000 | usd |
| CY2023Q2 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
146000 | usd |
| CY2022Q2 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
315000 | usd |
| us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain risks and concentrations</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have certain customers whose net sales individually represented 10% or more of our total net sales, or whose net trade accounts receivable balance individually represented 10% or more of our total net trade accounts receivable; we have certain suppliers, which individually represent 10% or more of our total purchases, or whose trade accounts payable balance individually represented 10% or more of our total trade accounts payable balance, as follows:</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June 30, 2023, sales to two U.S. Navy shipbuilders and a distributor to the U.S. Navy accounted for approximately 26% and 16% of net sales, respectively. When sales to our primary distributors for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 42% of net sales for the same period. For the three months ended June 30, 2022, sales to our primary distributor for the U.S. Navy, a regional commercial lighting retrofit company, and a commercial building systems provider accounted for approximately 22%, 14%, and 13% of net sales, respectively. When sales to our primary distributors for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 24% of net sales for the same period. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2023, sales to a U.S. Navy shipbuilder and a distributor to the Department of Defense accounted for approximately 23% and 11% of net sales, respectively. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 34% of net sales for the same period. For the six months ended June 30, 2022, sales to our primary distributor for the U.S. Navy, a U.S. Navy shipbuilder, and a regional commercial lighting retrofit company accounted for approximately 18%, 12%, and 12% of net sales, respectively. When sales to our primary distributor for the U.S. Navy are combined with sales to shipbuilders for the U.S. Navy, total net sales of products for the U.S. Navy comprised approximately 31% of net sales for the same period.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A distributor for the Department of Defense and a U.S. Navy shipbuilder accounted for approximately 24% and 14% of net trade accounts receivable, respectively, at June 30, 2023. At December 31, 2022, a distributor for the Department of Defense accounted for 25% of our net trade accounts receivable and a shipbuilder for the U.S. Navy accounted for 30% of our net trade accounts receivable.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No one supplier accounted for more than 10% of our total expenditures for the three and six months ended June 30, 2023. Two offshore suppliers accounted for approximately 19% and 10%, respectively, of our total expenditures for the three months ended June 30, 2022. For the six months ended June 30, 2022, one offshore supplier accounted for approximately 19% of our total expenditures.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2023, one offshore supplier accounted for approximately 31% of our trade accounts payable balance. At December 31, 2022, this offshore supplier accounted for approximately 36% of our trade accounts payable balance.</span></div> | ||
| CY2023Q2 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
3521000 | usd |
| CY2022Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
3347000 | usd |
| CY2023Q2 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
4183000 | usd |
| CY2022Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
4656000 | usd |
| CY2023Q2 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
2400000 | usd |
| CY2022Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
2527000 | usd |
| CY2023Q2 | us-gaap |
Inventory Net
InventoryNet
|
5304000 | usd |
| CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
5476000 | usd |
| CY2023Q1 | efoi |
Inventory Valuation Reserves Raw Materials
InventoryValuationReservesRawMaterials
|
2507000 | usd |
| CY2022Q1 | efoi |
Inventory Valuation Reserves Raw Materials
InventoryValuationReservesRawMaterials
|
3179000 | usd |
| CY2022Q4 | efoi |
Inventory Valuation Reserves Raw Materials
InventoryValuationReservesRawMaterials
|
2527000 | usd |
| CY2021Q4 | efoi |
Inventory Valuation Reserves Raw Materials
InventoryValuationReservesRawMaterials
|
3050000 | usd |
| CY2023Q2 | efoi |
Inventory Valuation Reserves Provision Accrual
InventoryValuationReservesProvisionAccrual
|
70000 | usd |
| CY2022Q2 | efoi |
Inventory Valuation Reserves Provision Accrual
InventoryValuationReservesProvisionAccrual
|
-56000 | usd |
| efoi |
Inventory Valuation Reserves Provision Accrual
InventoryValuationReservesProvisionAccrual
|
14000 | usd | |
| efoi |
Inventory Valuation Reserves Provision Accrual
InventoryValuationReservesProvisionAccrual
|
-201000 | usd | |
| CY2023Q2 | efoi |
Inventory Valuation Reserves Sales Of Inventory
InventoryValuationReservesSalesOfInventory
|
37000 | usd |
| CY2022Q2 | efoi |
Inventory Valuation Reserves Sales Of Inventory
InventoryValuationReservesSalesOfInventory
|
241000 | usd |
| efoi |
Inventory Valuation Reserves Sales Of Inventory
InventoryValuationReservesSalesOfInventory
|
113000 | usd | |
| efoi |
Inventory Valuation Reserves Sales Of Inventory
InventoryValuationReservesSalesOfInventory
|
257000 | usd | |
| CY2023Q2 | efoi |
Inventory Valuation Reserves Write Offs
InventoryValuationReservesWriteOffs
|
0 | usd |
| CY2022Q2 | efoi |
Inventory Valuation Reserves Write Offs
InventoryValuationReservesWriteOffs
|
202000 | usd |
| efoi |
Inventory Valuation Reserves Write Offs
InventoryValuationReservesWriteOffs
|
0 | usd | |
| efoi |
Inventory Valuation Reserves Write Offs
InventoryValuationReservesWriteOffs
|
202000 | usd | |
| CY2023Q2 | efoi |
Inventory Valuation Reserves Raw Materials
InventoryValuationReservesRawMaterials
|
2400000 | usd |
| CY2022Q2 | efoi |
Inventory Valuation Reserves Raw Materials
InventoryValuationReservesRawMaterials
|
2792000 | usd |
| CY2023Q2 | efoi |
Inventory Valuation Reserves Raw Materials
InventoryValuationReservesRawMaterials
|
2400000 | usd |
| CY2022Q2 | efoi |
Inventory Valuation Reserves Raw Materials
InventoryValuationReservesRawMaterials
|
2792000 | usd |
| CY2023Q2 | us-gaap |
Sublease Income
SubleaseIncome
|
0 | usd |
| CY2022Q2 | us-gaap |
Sublease Income
SubleaseIncome
|
56000 | usd |
| us-gaap |
Sublease Income
SubleaseIncome
|
0 | usd | |
| us-gaap |
Sublease Income
SubleaseIncome
|
81000 | usd | |
| CY2023Q2 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
115000 | usd |
| CY2022Q2 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
83000 | usd |
| CY2021Q3 | efoi |
Payroll Tax Credit Employee Retention Credit Under The Cares Act
PayrollTaxCreditEmployeeRetentionCreditUnderTheCARESAct
|
431000 | usd |
| CY2023Q2 | efoi |
Payroll Tax Credit Employee Retention Credit Under The Cares Act Current
PayrollTaxCreditEmployeeRetentionCreditUnderTheCARESActCurrent
|
445000 | usd |
| CY2023Q2 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
|
1392000 | usd |
| CY2022Q4 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
|
1392000 | usd |
| CY2023Q2 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
|
1332000 | usd |
| CY2022Q4 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
|
1316000 | usd |
| CY2023Q2 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
|
60000 | usd |
| CY2022Q4 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
|
76000 | usd |
| CY2023Q2 | us-gaap |
Depreciation
Depreciation
|
8000 | usd |
| CY2022Q2 | us-gaap |
Depreciation
Depreciation
|
43000 | usd |
| us-gaap |
Depreciation
Depreciation
|
16000 | usd | |
| us-gaap |
Depreciation
Depreciation
|
87000 | usd | |
| CY2023Q2 | us-gaap |
Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
|
0.0725 | |
| CY2023Q2 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P4Y | |
| us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
232000 | usd | |
| us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
215000 | usd | |
| CY2023Q2 | efoi |
Operating Lease Cost Net Of Sublease Income
OperatingLeaseCostNetOfSubleaseIncome
|
115000 | usd |
| CY2022Q2 | efoi |
Operating Lease Cost Net Of Sublease Income
OperatingLeaseCostNetOfSubleaseIncome
|
27000 | usd |
| efoi |
Operating Lease Cost Net Of Sublease Income
OperatingLeaseCostNetOfSubleaseIncome
|
232000 | usd | |
| efoi |
Operating Lease Cost Net Of Sublease Income
OperatingLeaseCostNetOfSubleaseIncome
|
134000 | usd | |
| CY2023Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
1034000 | usd |
| CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
1180000 | usd |
| CY2023Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
1125000 | usd |
| CY2022Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
1227000 | usd |
| CY2023Q2 | efoi |
Finance Lease Right Of Use Asset Gross
FinanceLeaseRightOfUseAssetGross
|
13000 | usd |
| CY2022Q4 | efoi |
Finance Lease Right Of Use Asset Gross
FinanceLeaseRightOfUseAssetGross
|
13000 | usd |
| CY2023Q2 | efoi |
Finance Lease Right Of Use Asset Accumulated Depreciation
FinanceLeaseRightOfUseAssetAccumulatedDepreciation
|
13000 | usd |
| CY2022Q4 | efoi |
Finance Lease Right Of Use Asset Accumulated Depreciation
FinanceLeaseRightOfUseAssetAccumulatedDepreciation
|
13000 | usd |
| CY2023Q2 | us-gaap |
Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
|
0 | usd |
| CY2022Q4 | us-gaap |
Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
|
0 | usd |
| CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
|
380000 | usd |
| CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
|
378000 | usd |
| CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
|
386000 | usd |
| CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
|
393000 | usd |
| CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
1537000 | usd |
| CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
412000 | usd |
| CY2023Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
1125000 | usd |
| CY2023Q2 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
94000 | usd |
| CY2022Q2 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
104000 | usd |
| us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
189000 | usd | |
| us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
240000 | usd | |
| CY2023Q2 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
0 | usd |
| CY2022Q2 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
0 | usd |
| us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
0 | usd | |
| us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
1000 | usd | |
| CY2020Q3 | efoi |
Debt Instrument Number Of Credit Facilities
DebtInstrumentNumberOfCreditFacilities
|
2 | creditfacility |
| CY2022Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
9200000 | usd |
| CY2021Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
9600000 | usd |
| CY2023Q2 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
|
37500000 | usd |
| CY2023Q2 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
0.0001 | |
| CY2023Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
| CY2020Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2020Q1 | efoi |
Percentage Of Series A Preferred Stock Eligible To Vote
PercentageOfSeriesAPreferredStockEligibleToVote
|
0.01582 | |
| CY2023Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
23000 | usd |
| CY2022Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
54000 | usd |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
49000 | usd | |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
98000 | usd | |
| CY2023Q2 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
100000 | usd |
| CY2022Q2 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
200000 | usd |
| us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y7M6D | ||
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
47103 | shares |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
13.78 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
11427 | shares | |
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
3.04 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
12203 | shares | |
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
19.38 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
3827 | shares | |
| us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
17.06 | ||
| CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
42500 | shares |
| CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
8.99 | |
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P9Y | ||
| CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
33951 | shares |
| CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
9.83 | |
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P8Y10M24D | ||
| CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
5786 | shares |
| CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
23.91 | |
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P7Y4M24D | ||
| CY2023Q2 | us-gaap |
Purchase Obligation
PurchaseObligation
|
2100000 | usd |
| CY2023Q2 | efoi |
Purchase Obligation Percentage
PurchaseObligationPercentage
|
0.80 |
